Skip to content
Search

Latest Stories

Ex-Haleon VP Bas Vorsteveld joins Kenvue

Kenvue appoints Bas Vorsteveld as area managing director for Northern Europe
Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

Bas Vorsteveld announced his departure from Haleon in October 2024, after “a journey of nearly 19 amazing years”

Bas Vorsteveld, former Haleon’s vice-president and general manager for Great Britain and Ireland (GBI), has been appointed as Kenvue's new area managing director for Northern Europe.

In his new role, he will oversee the company’s operations across the UK, Ireland, Norway, Sweden, Denmark, and Finland, managing a portfolio of iconic brands, including Nicorette, Aveeno, Johnson’s Baby, Listerine, Neutrogena, Calpol, OGX, and Imodium.


Vorsteveld has over 30 years of experience in consumer goods and healthcare.

At Haleon, he played a pivotal role in driving its GBI business following its separation from GSK, delivering significant growth and earning notable recognition, including Best Company at the UK Pharmacy Awards 2024.

He announced his departure from Haleon in October 2024, after “a journey of nearly 19 amazing years.”

Until recently, Vorsteveld was president of the board of the PAGB, spearheading the organisation’s five-year strategy focused on advancing self-care to help alleviate healthcare pressures.

He has held several roles across Europe with GSK Consumer Healthcare including VP & Head of Commercial Excellence EMEA, VP & General Manager France and French speaking Africa & Maghreb, and GM Benelux. Prior to that, he held GM roles at Novartis. He started his career at Campina.

Expressing his enthusiasm for the new role, Vorsteveld said: “Kenvue’s iconic brands speak for themselves, and I am excited by the truly holistic approach to self-care we can offer through the entire range of different categories we thrive in.

“I’m thrilled to join the Northern Europe team, and I look forward to getting out across the region to spend time with our customers and stakeholders across the industry as well as our dedicated team.”

Welcoming Bas to the leadership team, Carlton Lawson, group president, Europe, Middle East, Africa and Latin America at Kenvue, said: “With almost three decades of experience in consumer goods and healthcare, Bas brings a proven track record of delivering industry leading growth, building high performing teams and deep industry knowledge that will be invaluable as we work to further boost Kenvue’s regional performance and growth.

“I’m confident that his experience advocating for the role our industry can and should play in promoting the value of self-care will help us deliver on our clear purpose to put the power of everyday care into the hands of more consumers.”

More For You

NICE calls for annual BMI checks for adults with long-term conditions

Annual BMI measurements create early intervention opportunities for weight management

Getty Images

NICE seeks feedback on annual BMI checks for adults with long-term conditions

The National Institute for Health and Care Excellence (NICE) has published a draft quality standard recommending annual Body mass index (BMI) and waist-to-height measurements for adults with long-term conditions to help prevent weight-related complications.

A consultation has been launched to gather feedback from healthcare professionals and commissioners on the feasibility of implementing these proposals within the NHS.

Keep ReadingShow less
Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less
Morrison: Pharmacy contract news

Janet Morrison

Morrison: Pharmacy contract news “before the start of the financial year”


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Keep ReadingShow less
Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less